Cover_small_Seminar_2_2020.jpg

Frontiers in Drug Development Seminar on

Re-Engineering Preclinical Testing and and the Impact on First in Human Studies

February 13, 2020, Basel

more information will be availabla soon!

It is high time to rethink and improve preclinical testing to pave the way to optimise First in Human Studies. New concepts which focus on reducing, refining, replacing animal involvement in toxicology and pharmacology research will be introduced. Furthermore, this will change the way the first dose for humans is to be determined.
Safe the date and explore with us the new concepts of drug development methodologies

 

 

 

Format

1 day workshops, recognised for continuing professional development. The workshops are held on day four of each ECPM Course Module.

Credits

5 workshops over a period of two years equal 1 ECTS credit.
Accredited as continuing education by the Swiss Society of Pharmaceutical Medicine (SGPM), the Swiss Society of Pharmaceutical Professionals (SwAPP), and Swiss Association of Public Health Administration & Hospital Pharmacists (GSASA, 50 FPH credits Hospital Pharmacy)

Fee

680 CHF
580 CHF for ECPM Alumni and SwAPP/SGPM members
210 CHF for employees of universities and other nonprofit institutions


Cancellation Policy